Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics
- 31 October 2006
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 72 (1), 20-33
- https://doi.org/10.1016/j.antiviral.2006.03.005
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amidesBioorganic & Medicinal Chemistry Letters, 2005
- Structure−Activity Relationship Studies of a Series of Antiviral and Antibacterial Aglycon Derivatives of the Glycopeptide Antibiotics Vancomycin, Eremomycin, and DechloroeremomycinJournal of Medicinal Chemistry, 2005
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- Role of the Glycopeptide Framework in the Antibacterial Activity of Hydrophobic Derivatives of Glycopeptide AntibioticsJournal of Medicinal Chemistry, 2003
- Synthesis and biological properties of N63-carboxamides of teicoplanin antibiotics. Structure-activity relationshipsJournal of Medicinal Chemistry, 1989
- Function of the amino sugar and N-terminal amino acid of the antibiotic vancomycin in its complexation with cell wall peptidesJournal of the American Chemical Society, 1988
- Structural features that affect the binding of teicoplanin, ristocetin A, and their derivatives to the bacterial cell-wall model N-acetyl-D-alanyl-D-alanineJournal of the Chemical Society, Chemical Communications, 1985
- Structure and stereochemistry of ristosamineThe Journal of Organic Chemistry, 1974